Concord Medical Services Holdings (CCM) EBITDA (2016 - 2017)
Historic EBITDA for Concord Medical Services Holdings (CCM) over the last 9 years, with Q2 2017 value amounting to -$15.0 million.
- Concord Medical Services Holdings' EBITDA fell 7360.68% to -$15.0 million in Q2 2017 from the same period last year, while for Jun 2017 it was -$53.0 million, marking a year-over-year decrease of 3905.53%. This contributed to the annual value of -$44.1 million for FY2016, which is 16673.52% down from last year.
- As of Q2 2017, Concord Medical Services Holdings' EBITDA stood at -$15.0 million, which was down 7360.68% from -$8.6 million recorded in Q2 2016.
- Concord Medical Services Holdings' 5-year EBITDA high stood at $15.6 million for Q4 2013, and its period low was -$26.4 million during Q4 2015.
- In the last 5 years, Concord Medical Services Holdings' EBITDA had a median value of $3.6 million in 2014 and averaged $928985.1.
- As far as peak fluctuations go, Concord Medical Services Holdings' EBITDA skyrocketed by 21080.1% in 2014, and later crashed by 83913.77% in 2015.
- Over the past 5 years, Concord Medical Services Holdings' EBITDA (Quarter) stood at $15.6 million in 2013, then tumbled by 77.12% to $3.6 million in 2014, then crashed by 839.14% to -$26.4 million in 2015, then skyrocketed by 67.37% to -$8.6 million in 2016, then tumbled by 73.61% to -$15.0 million in 2017.
- Its EBITDA was -$15.0 million in Q2 2017, compared to -$8.6 million in Q2 2016 and -$3.0 million in Q1 2016.